Does TICAGRELOR Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with TICAGRELOR (Ticagrelor). This represents 0.0% of all adverse event reports for TICAGRELOR.
8
Reports of Malignant neoplasm progression with TICAGRELOR
0.0%
of all TICAGRELOR reports
3
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TICAGRELOR?
Of the 8 reports, 3 (37.5%) resulted in death, 3 (37.5%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TICAGRELOR. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TICAGRELOR Cause?
Dyspnoea (3,156)
Myocardial infarction (1,749)
Death (1,510)
Off label use (1,084)
Fatigue (1,081)
Chest pain (1,075)
Contusion (970)
Dizziness (811)
Vascular stent thrombosis (700)
Haemorrhage (676)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TICAGRELOR Alternatives Have Lower Malignant neoplasm progression Risk?
TICAGRELOR vs TICLOPIDINE
TICAGRELOR vs TIGECYCLINE
TICAGRELOR vs TIKOSYN
TICAGRELOR vs TILDRAKIZUMAB
TICAGRELOR vs TILDRAKIZUMAB-ASMN